AUBREE MCKNIGHT: Open Payments
NPI 1508225475 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 24 payments from 11 companies in 2025. Trend: 2023 $2,829 · 2024 $488 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 7 | $287 |
| SCPHARMACEUTICALS INC. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $37 |
| PFIZER INC. | 2 | $35 |
| Philips North America LLC | 1 | $34 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Chiesi USA, Inc. | 1 | $19 |
Products named: COREVALVE EVOLUT R, SYMPLICITY G3, FUROSCIX, LifeVest, VYNDAQEL, EPIQ CVx, VERQUVO, Kerendia.
Industry payments across AL — which companies pay providers there.
